Patent | Date |
---|
(AZA)Benzothiazolyl Substituted Pyrazole Compounds App 20220184041 - Cabral; Shawn ;   et al. | 2022-06-16 |
Tissue-specific genome engineering using CRISPR-Cas9 Grant 10,851,367 - Liras , et al. December 1, 2 | 2020-12-01 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 10,813,942 - Liras , et al. October 27, 2 | 2020-10-27 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20190321382 - Liras; Spiros ;   et al. | 2019-10-24 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 10,376,531 - Liras , et al. A | 2019-08-13 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20180296585 - Liras; Spiros ;   et al. | 2018-10-18 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 10,039,778 - Liras , et al. August 7, 2 | 2018-08-07 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20170165284 - Liras; Spiros ;   et al. | 2017-06-15 |
Tissue-specific Genome Engineering Using Crispr-cas9 App 20170137801 - Liras; Spiros ;   et al. | 2017-05-18 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 9,617,293 - Liras , et al. April 11, 2 | 2017-04-11 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Grant 9,439,902 - Mascitti September 13, 2 | 2016-09-13 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Grant 9,439,901 - Mascitti September 13, 2 | 2016-09-13 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20160207953 - Liras; Spiros ;   et al. | 2016-07-21 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 9,340,553 - Liras , et al. May 17, 2 | 2016-05-17 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Grant 9,308,204 - Mascitti April 12, 2 | 2016-04-12 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20150329555 - Liras; Spiros ;   et al. | 2015-11-19 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol Derivatives App 20150065512 - Mascitti; Vincent | 2015-03-05 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol Derivatives App 20150065513 - Mascitti; Vincent | 2015-03-05 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol Derivatives App 20150065565 - Mascitti; Vincent | 2015-03-05 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Grant 8,669,380 - Mascitti March 11, 2 | 2014-03-11 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol Derivatives App 20130225487 - Mascitti; Vincent | 2013-08-29 |
Gpr 119 Modulators App 20130072427 - Guimaraes; Cristiano ;   et al. | 2013-03-21 |
Imidazo-pyrazoles As Gpr119 Inhibitors App 20120295845 - Mascitti; Vincent ;   et al. | 2012-11-22 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol Derivatives App 20120184486 - Mascitti; Vincent | 2012-07-19 |
3-oxa-7-azabicyclo[3.3.1]nonanes App 20120095028 - DeNinno; Michael Paul ;   et al. | 2012-04-19 |
Gpr 119 Modulators App 20120052130 - Darout; Etzer ;   et al. | 2012-03-01 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Grant 8,080,580 - Mascitti , et al. December 20, 2 | 2011-12-20 |
Gpr 119 Modulators App 20110020460 - Mascitti; Vincent ;   et al. | 2011-01-27 |
Gpr 119 Modulators App 20100285145 - Darout; Etzer ;   et al. | 2010-11-11 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol Derivatives App 20100056618 - Mascitti; Vincent ;   et al. | 2010-03-04 |